Epidermal growth factor receptor (EGFR) is the most common driver gene mutation of NSCLC, with approximately 35% of Asian patients and 60% of patients with lung adenocarcinomas (Pi et al., 2018; Yoon et al., 2020). The gene discussed is EGFR; the disease is lung adenocarcinoma.